Navigation Links
Micromet Presents Data at ESMO 2008 on Anti-EpCAM Antibody Adecatumumab (MT201) in Combination with Chemotherapy
Date:9/15/2008

munity of professionals who share the common goal of providing optimal care to all cancer patients.

Through the years, the Society has strived to meet the needs of both oncologists and patients. For oncology professionals, ESMO serves and offers support to its members in their daily practice and careers by sharing knowledge and expertise through scientific and educational activities. For patients, ESMO partners with cancer patient associations and groups, by promoting direct and pro-active involvement of patients in educational, political, and networking activities. For the benefit of both, professionals and patients, in 2006 ESMO became active at the political level in order to influence issues which could impact the oncology community.

About Micromet, Inc.

Micromet, Inc. (http://www.micromet-inc.com) is a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Four of its antibodies are currently in clinical trials, while the remainder of the product pipeline is in preclinical development. The BiTE(R) antibody blinatumomab (MT103/MEDI-538) is in a phase 2 clinical trial for the treatment of patients with acute lymphoblastic leukemia and in a phase 1 clinical trial for the treatment of patients with non-Hodgkin's lymphoma. BiTE antibodies represent a new class of antibodies that activate a patient's own cytotoxic T cells, considered the most powerful "killer cells" of the human immune system, to eliminate cancer cells. Micromet is developing blinatumomab in collaboration with MedImmune, Inc., a subsidiary of AstraZeneca plc. MT110 is the second BiTE antibody in clinical trials, and is being developed by Micromet in a phase 1 clinical trial for the treatment of patients with lung or gastrointestinal cancer. The third clinical stage antibody is adecatumumab, also known as MT201, a human monoclonal antibody that tar
'/>"/>

SOURCE Micromet, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE
2. Micromet, Inc. to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results
3. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
4. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
5. Micromets BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkins Lymphoma
6. Micromet to Present Clinical Update for BiTE Antibody MT103/MEDI-538 at the International Conference on Malignant Lymphomas
7. Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
8. Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study
9. Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma
10. Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies
11. Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 23, 2014  Mezzion Pharma Co. Ltd., announced that ... use of udenafil to treat adolescents who have undergone ... The clinical program will follow protocols developed by a ... Network (PHN), a multi-center clinical research network funded by ... the National Institutes of Health (NIH). ...
(Date:7/23/2014)... 8,000 attendees will converge in Washington D.C. ... (RBC), taking place July 23-26 at the Gaylord National ... to "Lead Change" in the pharmacy profession, in their ... future. "RBC is the perfect opportunity for ... learn new ways they can lead change in healthcare ...
(Date:7/23/2014)... This September leading clinicians in orthodontics and ... for DOCtalk 2014 —a "Dynamic Orthodontic ... and private practitioner Dr. David Sarver , DOCtalk ... clinical and practice management efficiency and high quality patient ... to welcome fresh thinking and join a community of ...
Breaking Medicine Technology:Mezzion Pharma Initiates Clinical Development Program To Evaluate Udenafil In Adolescents With Single Ventricle Heart Defects 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 3Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 4Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 62014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3
... N.M., June 3, 2011 Rep. Ed Whitfield, R-Ky., ... that will set federal minimum education and certification standards ... planning and delivering all medical imaging examinations and radiation ... Excellence ( CARE ) in Medical Imaging and Radiation ...
... 3, 2011 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ... Sachs 32nd Annual Global Healthcare Conference on Wednesday, June 8, ... Interested parties may access a live webcast of ... It is recommended that listeners log on ...
Cached Medicine Technology:Medical Imaging and Radiation Therapy Personnel Certification Bill Introduced in Congress 2Medical Imaging and Radiation Therapy Personnel Certification Bill Introduced in Congress 3Onyx Pharmaceuticals to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference 2
(Date:7/23/2014)... the University of Exeter has developed a simple, ... frequently fatal lung disease which attacks immune deficient ... transplant recipients. , The lateral-flow device (LFD), created ... a notoriously difficult to diagnose disease caused by ... , Invasive aspergillosis is a leading cause of ...
(Date:7/23/2014)... Randy Dotinga HealthDay Reporter ... A powerful drug combo may not be as effective ... on human cells suggests that one of the medications ... this study,s findings aren,t definitive, and there,s still hope ... and lumacaftor, according to the study,s senior author. ...
(Date:7/23/2014)... 23, 2014 Home Care Assistance ... for seniors, is proud to announce the next installment ... in a wide range of health and wellness-related fields. ... and award-winning author Nancy Kriseman, and will cover the ... prevent burnout by becoming more self-aware. In particular, Nancy ...
(Date:7/23/2014)... in Shaanxi province, and the University of California, Davis, ... groundwork for establishing the Sino-U.S. Joint Research Center for ... held in the city of Yingchuan, China, during a ... Agriculture and China,s Ministry of Science and Technology. , ... and for our World Food Center and serves as ...
(Date:7/23/2014)... Thousands of DePuy Pinnacle hip lawsuits ... federal multidistrict litigation underway in U.S. District Court, Northern ... an Order dated July 18th, U.S. District Judge Ed ... a $1,000 fee for the preservation and return of ... things, the Order noted that there is no evidence ...
Breaking Medicine News(10 mins):Health News:New device detects deadly lung disease 2Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 2Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 3Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 2Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 3Health News:Global food safety research agreement signed by China and UC Davis 2Health News:Global food safety research agreement signed by China and UC Davis 3Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 4
... women in the United States will have an osteoporosis-related fracture ... published in the May 2010 issue of the Journal ... a few of these women will be tested and treated ... their risk of future fractures. "Less than 10 percent ...
... ... Affiliates Medical Group, a Torrance, California-based healthcare organization, today announced the acquisition of ... 67,000 managed care patients in Los Angeles County and Orange County, California. ... Torrance, ...
... friends and good communication are key, study finds , ... an important role in preventing their children from becoming ... know their friends, a new study suggests. , ... could have a substantial impact on child bullying," said ...
... A new study shows that a family of molecules ... control many important functions in healthy cells, but that ... , The research, led by scientists at the ... Hospital and Richard J. Solove Research Institute in collaboration ...
... feel that their Government has managed the financial crisis quite well. ... two of the findings presented in a new report by the ... of what may be the worst financial crisis since the 1930s, ... in a new SOM report presented Tuesday at a seminar at ...
... Best practices for managing medical emergencies in dental clinics ... advances in knowledge and the development of new medications ... School of Dental Medicine and an expert on dental ... an updated list of emergency medications and equipment for ...
Cached Medicine News:Health News:Women want answers, but what questions should be asked? 2Health News:Women want answers, but what questions should be asked? 3Health News:HealthCare Partners Medical Group Expands to Orange County. HealthCare Partners and Talbert Medical Group Join Forces 2Health News:HealthCare Partners Medical Group Expands to Orange County. HealthCare Partners and Talbert Medical Group Join Forces 3Health News:Involved Parents Less Likely to Raise Bullies 2Health News:Cancer cells show rewired, fragmented microRNA networks 2Health News:Swedes think highly of the government -- but not of the royal family 2Health News:New emergency preparedness information available for dental offices 2
... ACONO H. pylori Rapid Test Strip and ... qualitative detection of antibodies to Helicobacter pylori ... plasma to aid in the diagnosis of ... of age and older. They are intended ...
... is a lateral-flow immuno-chromatographic assay intended for ... specific to Helicobacter pylori in human serum, ... convenient, non-invasive, and easy to perform test ... of H.pylori infection in patients with clinical ...
... The Trinity Biotech Uni-Gold™ H. ... rapid, in vitro qualitative detection of ... pylori) in adult human serum, plasma ... in the diagnosis of H. pylori ...
... FDA approved rapid point-of-care fingerstick ... used to aid in the ... CLIA waived test, which detects ... HIV-1, requires only a drop ...
Medicine Products: